SCHEMBL3659010

SCHEMBL3659010

CCCCOC(=O)N[C@@H](CCc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.61
SIRT2 Q8IXJ6 1/20 0.52
SIRT1 Q96EB6 1/20 0.52
CTSL P07711 4/20 0.50
GAA P10253 1/20 0.50
CTSS P25774 1/20 0.50
TGM2 P21980 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.48
RECQL P46063 1/20 0.48
RAB9A P51151 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ACE P12821 1/20 0.47
ACE2 Q9BYF1 1/20 0.47
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8142303 1.00 CTSK (0.61) CTSKSIRT2SIRT1CTSLGAA
SCHEMBL3630687 1.00 CTSK (0.61) CTSKSIRT2SIRT1CTSLGAA
SCHEMBL3719520 0.94 CTSK (0.63) CTSKSIRT2SIRT1CTSLGAA
SCHEMBL16465117 0.91 CTSK (0.60) CTSKSIRT2SIRT1CTSLGAA
SCHEMBL6684832 0.89 TGM2 (0.49) CTSKTGM2SMN1; SMN2NPC1RAB9A
SCHEMBL5206542 0.89 CTSK (0.58) CTSKSIRT2SIRT1CTSLCTSS
SCHEMBL5177894 0.88 CTSK (0.48) CTSKSIRT2SIRT1CTSLGAA
SCHEMBL844471 0.86 ITGB3 (0.58) CTSKCTSLCTSSACEACE2
SCHEMBL2185240 0.86 ITGB3 (0.58) CTSKCTSLCTSSACEACE2
SCHEMBL7758997 0.86 ITGB3 (0.58) CTSKCTSLCTSSACEACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234982-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009080523-A1 SUBSTITUTED HYDANTOINS AS MEK KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2009-07-02 WO disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed